The2019-nCoVIgM/IgGAntibodyTestKitfromHiprowascertifiedbyBrazilANVISA
CEcertificationforHipro’s2019-nCoVIgMIgGAntibodyTestKit
ThreebatchesofMedicalmaterialsdonatedbyHiprotoHuBei&ShanXiProvince.
HiproBiotechnologyGMBHawholly-ownedsubsidiaryofHiproBiotechnologyCo.,Ltd.,locatedatFreiburg,Germany.
In2016,Hiproestablishedawholly-ownedsubsidiaryinSanFrancisco,California,USA.
HiproheldanationaltechnicaltraininginShijiazhuangforthemarketingpersonnelinJan21-25,2015.
HiprohaslaunchedtheestablishmentofJiangsuBranchatTaizhou—Chinamedicalcity.36700sq.m.landintaizhouisusedforconstructionforR&D,production,administratio
OnApril22,HiproandAffimedixheldalauncheventofHiproproductpresentationinMumbai,India.